Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

Roflumilast is used for treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...